NeoPharm CO., LTD. (KOSDAQ:092730)

South Korea flag South Korea · Delayed Price · Currency is KRW
14,270
-60 (-0.42%)
May 30, 2025, 3:30 PM KST
-49.49%
Market Cap 224.14B
Revenue (ttm) 122.41B
Net Income (ttm) 24.09B
Shares Out 15.64M
EPS (ttm) 1,540.00
PE Ratio 9.31
Forward PE n/a
Dividend 600.00 (4.19%)
Ex-Dividend Date Dec 27, 2024
Volume 60,311
Average Volume 95,881
Open 14,450
Previous Close 14,330
Day's Range 14,110 - 14,600
52-Week Range 10,075 - 34,300
Beta 0.50
RSI 55.93
Earnings Date May 2, 2025

About NeoPharm CO., LTD.

NeoPharm CO., LTD. engages in the manufacturing and sale of skin care products in South Korea. The company provides Atopalm, a non-steroid product for sensitive and dry skin; skin dermo-cosmetic products under the Real Barrier brand name; sensitive, dry, oily, or trouble-prone skin care products under the ZEROID brand; body moisturizers under the Derma-B brand name; sport care products under the MISSION ATHELETCARE brand; and dermArtlogy, a 1:1 consulting cosmetic brand. NeoPharm CO., LTD. was founded in 2000 and is headquartered in Daejeon, So... [Read more]

Founded 2000
Employees 172
Stock Exchange KOSDAQ
Ticker Symbol 092730
Full Company Profile

Financial Performance

In 2024, NeoPharm CO., LTD.'s revenue was 119.01 billion, an increase of 22.56% compared to the previous year's 97.10 billion. Earnings were 23.06 billion, a decrease of -0.64%.

Financial Statements

News

There is no news available yet.